INGREZZA (Neurocrine Biosciences, Inc.)
Welcome to the PulseAid listing for the INGREZZA drug offered from Neurocrine Biosciences, Inc.. This Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Neurocrine Biosciences, Inc. |
| NON-PROPRIETARY NAME: | Valbenazine |
| SUBSTANCE NAME: | VALBENAZINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-04-20 |
| END MARKETING DATE: | 0000-00-00 |
INGREZZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | INGREZZA from Neurocrine Biosciences, Inc. |
| LABELER NAME: | Neurocrine Biosciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/1) |
| START MARKETING DATE: | 2017-04-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70370-1040_70542128-491f-41c9-8ec2-fd228ecfbc5c |
| PRODUCT NDC: | 70370-1040 |
| APPLICATION NUMBER: | NDA209241 |
Other VALBENAZINE Pharmaceutical Manufacturers / Labelers:
